Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
- PMID: 11371748
- DOI: 10.1097/00019052-200106000-00003
Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
Abstract
Renewed interest in axonal injury in multiple sclerosis has significantly shifted the focus of research into this disease toward neurodegeneration. During the past year magnetic resonance and morphologic studies have continued to confirm and extend the concept that axonal transection begins at disease onset, and that cumulative axonal loss provides the pathologic substrate for the progressive disability that most long-term MS patients experience. Although inflammation and chronic demyelination are probable causes of axonal transection, little is known about the molecular mechanisms that are involved. The view that MS can also be considered an inflammatory neurodegenerative disease has important clinical implications for therapeutic approaches, monitoring of patients, and future treatment strategies.
Similar articles
-
Imaging neuronal and axonal degeneration in multiple sclerosis.Neurol Sci. 2003 Dec;24 Suppl 5:S283-6. doi: 10.1007/s10072-003-0175-2. Neurol Sci. 2003. PMID: 14652790 Review.
-
[Neuronal injury in multiple sclerosis].Medicina (B Aires). 2006;66(5):472-85. Medicina (B Aires). 2006. PMID: 17137182 Spanish.
-
Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.J Neuroimaging. 2004 Jul;14(3 Suppl):5S-10S. doi: 10.1177/1051228404266263. J Neuroimaging. 2004. PMID: 15228754 Review.
-
Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent N-acetylaspartate.Neuroimage Clin. 2017 Jun 22;15:780-788. doi: 10.1016/j.nicl.2017.06.028. eCollection 2017. Neuroimage Clin. 2017. PMID: 28702353 Free PMC article.
-
[Axonal damage in multiple sclerosis].Neurol Neurochir Pol. 2002 May-Jun;36(3):505-12. Neurol Neurochir Pol. 2002. PMID: 12185807 Review. Polish.
Cited by
-
Immunity and inflammation in neurodegenerative diseases.Am J Neurodegener Dis. 2013 Jun 21;2(2):89-107. Print 2013. Am J Neurodegener Dis. 2013. PMID: 23844334 Free PMC article.
-
The role of clinical and instrumented outcome measures in balance control of individuals with multiple sclerosis.Mult Scler Int. 2013;2013:190162. doi: 10.1155/2013/190162. Epub 2013 May 25. Mult Scler Int. 2013. PMID: 23766907 Free PMC article.
-
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.Int J Mol Sci. 2022 Mar 21;23(6):3383. doi: 10.3390/ijms23063383. Int J Mol Sci. 2022. PMID: 35328802 Free PMC article. Review.
-
A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination.Glia. 2019 Apr;67(4):650-667. doi: 10.1002/glia.23559. Epub 2019 Jan 9. Glia. 2019. PMID: 30623975 Free PMC article.
-
Diffusion tensor imaging in acute optic neuropathies: predictor of clinical outcomes.Arch Neurol. 2012 Jan;69(1):65-71. doi: 10.1001/archneurol.2011.243. Epub 2011 Sep 12. Arch Neurol. 2012. PMID: 21911658 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous